RNPAX
Price
$67.58
Change
-$0.91 (-1.33%)
Updated
Jul 13 closing price
Net Assets
170.23B
TWGGX
Price
$11.89
Change
-$0.19 (-1.57%)
Updated
Jul 13 closing price
Net Assets
550.93M
Interact to see
Advertisement

RNPAX vs TWGGX

RNPAX vs TWGGX Comparison Chart in %
View a ticker or compare two or three
VS
RNPAX vs. TWGGX commentary
Jul 14, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is RNPAX is a Hold and TWGGX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RNPAX has more cash in the bank: 170B vs. TWGGX (551M). RNPAX pays higher dividends than TWGGX: RNPAX (0.37) vs TWGGX (0.07). RNPAX was incepted earlier than TWGGX: RNPAX (24 years) vs TWGGX (28 years). RNPAX (1.49) is less costly to investors than TWGGX (1.10). TWGGX is a more actively managed with annual turnover of: 68.00 vs. RNPAX (23.00). RNPAX has a lower initial minimum investment than TWGGX: RNPAX (250) vs TWGGX (2500). RNPAX annual gain was more profitable for investors over the last year : 6.13 vs. TWGGX (0.41). RNPAX return over 5 years is better than : 8.01 vs. TWGGX (-20.49).
RNPAXTWGGXRNPAX / TWGGX
Total Expense Ratio1.491.10135%
Annual Report Gross Expense Ratio1.491.10135%
Fund Existence24 years28 years-
Gain YTD4.9056.15180%
Front LoadN/AN/A-
Min. Initial Investment250250010%
Min. Initial Investment IRAN/AN/A-
Net Assets170B551M30,853%
Annual Yield % from dividends0.370.07501%
Returns for 1 year6.130.411,492%
Returns for 3 years29.9212.56238%
Returns for 5 years8.01-20.49-39%
Returns for 10 years95.1812.74747%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
GERIX13.96N/A
N/A
Goldman Sachs Em Mkts Eq Insghts Intl
MEURX34.28N/A
N/A
Franklin Mutual International Value Z
HBGHX16.55N/A
N/A
Hartford Healthcare HLS IB
PREIX196.62N/A
N/A
T. Rowe Price Equity Index 500
PSVDX22.97N/A
N/A
PGIM Quant Solutions Small-Cap Val R2